References: Overview of modifiable lifestyle risk factors for atherosclerotic cardiovascular disease

Australian Diabetes Society (ADS), Diabetes Australia (DA). Australian type 2 diabetes glycaemic management algorithm. Sydney: ADS/DA; 2022. https://diabetessociety.com.au/position-statements-guidelines-type-2.asp
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41(1):111-88. https://www.ncbi.nlm.nih.gov/pubmed/31504418
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42(34):3227-337. https://www.ncbi.nlm.nih.gov/pubmed/34458905
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39(33):3021-104. https://www.ncbi.nlm.nih.gov/pubmed/30165516